---
figid: PMC6115354__kjpp-22-577-g008
figlink: /pmc/articles/PMC6115354/figure/F8/
number: F8
caption: Both G protein-coupled receptor- and nitric oxide-mediated intracellular
  signaling pathways are involved in changes in the contraction or relaxation of bladder
  smooth muscle. Grey symbols () indicate signaling pathway differences between normal
  and DM rats. Phospholipase C generates the intracellular second messenger IP3 from
  the membrane lipid PIP2. IP3 then induces Ca2+ release and the released Ca2+ binds
  to calmodulin. Ca2+/calmodulin activates MLCK, which phosphorylates myosin light
  chain, thus leading to contraction. In bladder smooth muscles from DM rats, changes
  in G protein-coupled receptor-mediated phospholipase C signaling affects IP3-dependent
  Ca2+ release and changes in PDE5 affect contraction or relaxation. These factors
  are expected to result in a decrease in bladder contractility. DM, diabetes mellitus;
  EFS, electrical field stimulation; PIP2, phosphatidylinositol 4,5-bisphosphate;
  PLC, phospholipase C; DAG, diacylglycerol; IP3, inositol trisphosphate; CaM, calmodulin;
  MLCK, myosin light chain kinase; MLC-P, myosin light chain phosphatase; NO, nitric
  oxide; PKG, protein kinase G; PDE5, phosphodiesterase 5.
pmcid: PMC6115354
papertitle: The change of signaling pathway on the electrical stimulated contraction
  in streptozotocin-induced bladder dysfunction of rats.
reftext: Jong Soo Han, et al. Korean J Physiol Pharmacol. 2018 Sep;22(5):577-584.
pmc_ranked_result_index: '85678'
pathway_score: 0.9541823
filename: kjpp-22-577-g008.jpg
figtitle: Change of signaling pathway on the electrical stimulated contraction in
  streptozotocin-induced bladder dysfunction of rats
year: '2018'
organisms: Homo sapiens
ndex: e1903f57-dee7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6115354__kjpp-22-577-g008.html
  '@type': Dataset
  description: Both G protein-coupled receptor- and nitric oxide-mediated intracellular
    signaling pathways are involved in changes in the contraction or relaxation of
    bladder smooth muscle. Grey symbols () indicate signaling pathway differences
    between normal and DM rats. Phospholipase C generates the intracellular second
    messenger IP3 from the membrane lipid PIP2. IP3 then induces Ca2+ release and
    the released Ca2+ binds to calmodulin. Ca2+/calmodulin activates MLCK, which phosphorylates
    myosin light chain, thus leading to contraction. In bladder smooth muscles from
    DM rats, changes in G protein-coupled receptor-mediated phospholipase C signaling
    affects IP3-dependent Ca2+ release and changes in PDE5 affect contraction or relaxation.
    These factors are expected to result in a decrease in bladder contractility. DM,
    diabetes mellitus; EFS, electrical field stimulation; PIP2, phosphatidylinositol
    4,5-bisphosphate; PLC, phospholipase C; DAG, diacylglycerol; IP3, inositol trisphosphate;
    CaM, calmodulin; MLCK, myosin light chain kinase; MLC-P, myosin light chain phosphatase;
    NO, nitric oxide; PKG, protein kinase G; PDE5, phosphodiesterase 5.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MLC1
  - GNA14
  - GNAQ
  - PLCD3
  - PRKG1
  - PLCZ1
  - PLCD4
  - NT5C2
  - GNA11
  - GNA15
  - PLCG2
  - PLCE1
  - KRIT1
  - PLCB1
  - PLCG1
  - PLCB4
  - PLCB2
  - EFS
  - PLCB3
  - PLCD1
  - Achetylcholine
  - Ca2+
  - Adenosine A
  - Guanylyl
  - CGMP
  - GMP
genes:
- word: MLC-P
  symbol: MLC
  source: hgnc_alias_symbol
  hgnc_symbol: MLC1
  entrez: '23209'
- word: (Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA14
  entrez: '9630'
- word: (Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: GMP
  symbol: GMP
  source: hgnc_alias_symbol
  hgnc_symbol: NT5C2
  entrez: '22978'
- word: (Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: (Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA15
  entrez: '2769'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: CaM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: EFS
  symbol: EFS
  source: hgnc_symbol
  hgnc_symbol: EFS
  entrez: '10278'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
chemicals:
- word: Achetylcholine
  source: ''
  identifier: ''
- word: Ca2+
  source: MESH
  identifier: D002118
- word: Adenosine A
  source: MESH
  identifier: D000241
- word: Guanylyl
  source: MESH
  identifier: C029859
- word: CGMP
  source: MESH
  identifier: C016276
- word: GMP
  source: MESH
  identifier: C068152
diseases: []
figid_alias: PMC6115354__F8
redirect_from: /figures/PMC6115354__F8
figtype: Figure
---
